Gabrielle retweeted
Great work of mental health screening in veteran women by @NicoleFleege #ASCOQLTY24
Gabrielle retweeted
#ASCOQLTY24 @DrLolaFayanju giving a MASTER CLASS on how to think about collecting health related social risks/needs data in an evidence-based way...
all leading to the launch of her trial NCT06019988 assessing HRSR, SDoH and enhanced navigation.
Gabrielle retweeted
We present the 1st national study on how unprepared HCWs feel in legal counseling & how a structured legal literacy intervention improved their skills. Congrats to star mentee Krista Chen MS4 & @TriageCancer, w/ Krista receiving an @ASCO Merit Award! #ASCOQLTY24 @ONealCancerUAB
Gabrielle retweeted
"Focusing on the patient experience is a powerful driver. We are all aligned in our ultimate goal.
Patient-centered care is good business."
Dr @EthanBasch1 the Joe Simone Award lecture at @ASCO #ASCOQLTY24
"On the Verge of a Golden Age in Quality Cancer Care"
Dr @EthanBasch1 receives the Joe Simone Award @ASCO #ASCOQLTY24 for his career developing the field of patient reported outcomes to improve patient-centered care.
Gabrielle retweeted
Congrats to @NicoleFleege who presented her work today on disparities in mental health screening in veteran woman with breast cancer. #ASCOQLTY24 @UIowaCancer @GRocqueMD
Amazing talk by Natalie Dickson and their great program. Well done! #ASCOQLTY24
Dr Natalie R. Dickson @TNOncology discusses a patient navigation program #ASCOQLTY24: how to build it, how to sustain it, and how to measure appropriate outcomes.
Congrats @EthanBasch1! Well deserved!!
We're pleased to honor Ethan Basch, MD, MSc, FASCO, with the Joseph Simone Quality Care Award at #ASCOQLTY24. Read more: brnw.ch/21wL0cO @Ethanbasch1
Very happy to see this one in press, we will need new strategies to engage diverse populations in #ePROs ascopubs.org/doi/10.1200/OP.…
@ONealCancerUAB @EthanBasch1 @NicoleECaston @cphilwil @Nikhende @DambraDent @Jeffie__F @Angela_M_Stover @bjweiner @UofSouthAlabama
Oncologist review of #ePROs in treatment decision-making can support patient-centered care. Thank you @AmericanCancer for supporting this work! @ONealCancerUAB
link.springer.com/article/10…
Gabrielle retweeted
Louder for those in the back! Research is only meaningful if it can equitable reach the populations it is supposed to serve. Thank you Dr. Krzynzanowska for this nuances discussion. #ASCO24 @ASCO @HemOncWomenDocs #CareDelivery #Policy #ImplementationScience cc: @GRocqueMD
Gabrielle retweeted
In an editorial published in @JAMA_current, @StephWheelerUNC, PhD, MPH, and colleagues endorse the use of simulation models to assess the impact of cancer control initiatives. @ethanbasch1 @GRocqueMD unclineberger.org/news/simul…
Unpacking oncologist psychology around #optimization (reducing chemotherapy) in #cancer is fascinating @awolff @LaurenWallner @LynneWagnerPhD @ONealCancerUAB
Excited to announce that one of my favorite articles I've ever written has been published 🤗 @GRocqueMD
Come read about why optimization-focused clinical trials in cancer care are necessary yet psychologically tricky for oncologists!
onlinelibrary.wiley.com/doi/…
Gabrielle retweeted
If there is only one thing you need to learn from #ascoqlty23, it's navigation works. Now CMS is ready to pay according to the latest news! @RyanNipp @GRocqueMD @ramy cms.gov/newsroom/press-relea…
It’s a wrap. Great friends, great science, great leadership @cardismith #ASCOQLTY23
This Post is from an account that no longer exists. Learn more
Incredible perspective by patient advocate @coffeemommy on MCED testing. We need more people like her participating in discussions. #ASCOQLTY23
Gabrielle retweeted
Such a thoughtful discussion of engaging patients with serious mental illness and cancer by @KellyIrwin_MD #ASCOQLTY23 – at Boston, MA
Gabrielle retweeted
Dr @manalipatelmd "physicians should not be dictating what patients should want at the end of life" #ASCOQLTY23
Gabrielle retweeted
Ms Emily Hayes Wood, BA, MPH presents at #ASCOQLTY23 on how community-academic partnerships can help overcome community-identified needs for marginalized populations
1⃣100% completed treatment
2⃣dx to tx time 83 ➡️ 43 days
3⃣34% actively participated in a #clinicaltrial

































